A prospective randomized trial to compare the effectiveness of honey vs. silver sulfadiazine dressing in burn wound management

K. N. Choudhary 1, S. K. Mohanty 2, P. Soni 3

1Dr. K N Choudhary, Associate Professor, Department of Surgery, 2Lt. Col. Dr. S K. Mohanty, Director Professor, Department of Surgery, Chhattisgarh Institute of Medical Sciences, Bilaspur, CG., 3Dr. P  Soni, Professor, Department of Surgery, Chhattisgarh Institute of Medical Sciences, Bilaspur, CG.

Address for Correspondence: Dr. K. N. Choudhary, SMIG-28, Parijat Castle, Ring Road – 2, Gaurav Path, Bilaspur, Chhattisgarh, Email:  kn_nutan@yahoo.co.in



Abstract

Introduction: In tribal part of central India burn injuries is a major cause of morbidity and mortality. This trail carried out at Chhattisgarh institute of medical sciences, Bilaspur intended to evaluate the efficacy and outcome of local application of honey vs. conventional silver sulfadiazine dressing treatment of burn wound. Methods: The study encompasses 200 patient of burn injury of varied aetiology admitted in burn ward whose total body surface area of burn was 15% to less than 50%. The patient receiving local application of honey were in group I (n=100) and those with conventional silver sulfadiazine ointment dressing treatment formed group II (n=100). Honey local application dressing was done on alternate day for 6 weeks of follow up period. The major outcome was, complete healing after 6 weeks period, while wound healing status was assessed at 2 weeks interval. Result: 52 out of 100 subject in honey treated group achieved complete healing as compare to 16 out of 100 subjects in silver sulfadiazine treated group. There was significant decrease in wound surface area, pain score & increase in comfort score in honey treated group in comparison to silver sulfadiazine ointment treated group at 0.00 level of significance. Conclusion: Markedly inexpensive honey as local application is highly effective in achieving complete healing in burn wound and is a very use full alternative for burn wound management.

Keywords - Honey local application, Silver Sulfadiazine Ointment & Burn Wound



Manuscript received: 30th Dec 2015, Reviewed: 07th Jan 2016
Author Corrected: 20th Jan 2016, Accepted for Publication: 31st Jan 2016

Introduction

The present trial was under taken in teaching hospital of tribal dominated region of Chhattisgarh where state of art health care services are meagre and incidence of burn casualties are very common. Infection in burn patient is a leading cause of morbidity & mortality posing immense management problem for the health care personal [1, 2].

Various topical agents with varying degree of success have been used to prevent complication in burn wound [3,4] . Honey is used as a wound dressing in traditional Indian medicine [5]. In recent times this has been rediscovered as a topical antibacterial agent for treatment of wound & burn [6]. It quickly reduces the inflammation, swelling, pain & unpleasant odours. It also facilitates separation of necrotic tissue without the need for debridement [7]. The honey dressing can be removed painlessly without causing damage to regrowing tissue [8, 9]. Honey may provide nutrients needed for regenerating tissues because it contains large quantities of readily assailable sugars, many amino acids, vitamins and trace elements. Its high vitamin C content may prove beneficial by promoting collagen synthesis [10]. In this era of super speciality and multi disciplinary approach in well equipped burn units, available at very high cost, the health care provider seldom talk about low cost burn wound treatment. Since there is no randomised controlled trial comparing the effect of honey with silver sulfadiazine ointment, we conducted this trial to compare the effect of honey with silver sulfadiazine ointment. Honey is not a difficult commodity in tribal area of Chhattisgarh.

This study was planned to assess effectiveness of Honey over Silver Sulfadiazine.

Patient and Method

Settings: This trial was conducted in Burn Centre of Department of General Surgery, Chhattisgarh Institute of Medical Sciences from 1st September 2014 to 31st August 2015. The ethical committee CIMS approved the study.

Inclusion Criteria

A total of 434 patients admitted in burn ward from 1st September 2014 to 31st August 2015. The patients were having total Burn surface area (TBSA) between 15% - 50% (n = 200) were included in the study. The patient included adults and children of both sexes who had diverse burn aetiology viz. flame, scald, electricity etc.

Exclusion criteria

The remaining 234 patient not adhering to the study plan were excluded from the study -
(1) Those who either expired or got discharged within one week of admission.
(2)  Patient who had more than 50% TBSA and were referred to nearby higher centre on request.
(3) Some cases of electric burn having full thickness damage (muscle or bone deep) because some form of reconstructive procedure was anticipated in early stage of hospitalisation.

Methods of burn wound management: All 200 patients received treatment as per protocol like resuscitation, intravenous fluids, antibiotics, analgesics, nutrition supplement, physiotherapy etc. Delayed conservative approach of Burn wound management was used in all cases, instead of early active debridement and skin grafting. Patients were divided into group - I and II of 100 each. This division in groups was based on the basis of fixed days of admission in a particular unit system of Surgery department irrespective of age, sex, aetiology of burn, TBSA etc. Either group in a particular unit had decided to adopt a separate protocol of burn wound management. In group - I (n = 100), burn wound was managed by commercially available Honey as local application, alternate day with sterile gauze by paramedical staff. In group- II (n = 100), burn wound was managed by conventional dressing treatment with silver sulfadiazine ointment. Dressing was changed every alternate day.

Patient in both group were initially cleaned with normal saline followed by removal of loose skin and puncture of blisters.

In study group, after local application of honey, patients were cleaned with clean cloth. After 5 to 7 days a dry and adherent crust (eschar) developed over the wound which started to separate out, gradually leaving a granulating surface in 1 to 3 weeks. Honey as local application was continued over the remaining wound.

All patients were subjected to routine haematological evaluation once a week and swab culture sensitivity fortnightly. After haemogram estimation, blood transfusion was given to patients, as and when necessary. The observation of wound healing status was made at 2 week intervals i.e. 2nd, 4th and 6th weeks in all patients. In both groups, the incidence of febrile episode and hyperpyrexia was recorded. The pain and over all comfort was recorded on a visual analogue scale (VAS) and any adverse reaction was recorded in all patients as per protocol.

Outcome variables: The main outcome of interest was complete healing at the end of the 6th week. Secondary outcome were reduction in surface area of burn would measured by Wallace Rule of Nine and pain during dressing change measured on visual Analogue Scale (VAS 0 – 10) and over all comfort of subjects during hospitalisation measured on the VAS of 0 – 10.

Statistical Analysis: Paired t – tests were used to find out the difference between the two groups. Data analysis was performed on SPSS software (Version 11.5). A P value of < 0.05 was accepted as significant.

Result

In honey treated group of 95 subjects completed the follow up. Five subject suffered multi organ failure and death and were excluded from outcome analysis. In silver sulfadiazine group seven subject suffered multi organ failure and death and were excluded from outcome analysis.

Table – I describes the demographic and biochemical baseline characteristics. There was female preponderance in both the group. Both the groups were comparable in terms of demographic characteristics, aetiology and location of burn wound. Similarly both groups were comparable in terms of concomitant disease, previous medical and surgical treatments. Most subjects had burn wound of flame burn/ flash burn. Two groups were comparable in terms of burn surface area, pain score during dressing and overall comfort score during hospitalisation.

Proportion of complete healing at 6 weeks: In the honey group, 52 subjects achieved complete healing of burn wound at six weeks. Only 16 subjects attained complete healing with silver sulfadiazine in 6 weeks.

Surface area reduction: Median surface area of burn wound was 27.67% at baseline (0 week) in the silver sulfadiazine group which reduced to 8.86% (Residual burn surface area) at 6th week. In the honey group, baseline median surface area was 28.05% which reduced to 2.91% (Residual burn wound) at 6th week. The difference was significant at < 0.05% levels (Table 2 and 3).

Pain score on Visual Analogue Scale (VAS): Median pain score as baseline was 7 on 11 point scale of 0 – 10. This reduced to 1 at the 6th week in the honey treated group. Patients in the silver sulfadiazine group experienced a reduction in pain score from 7 at baseline to 5 at the 6th week (Table 2 and 3).

Overall comfort score on Visual Analogue Scale (VAS): Median overall comfort score at baseline was 4 which markedly increased to 9 at the 6th week in the honey treated group (Table – 2). Patients in Silver sulfadiazine group experienced increase in overall comfort score from 4 at baseline to 6 at the sixth week.

The group in which honey application was used did not require frequent use of analgesics, contrary to silver sulfadiazine group in which analgesics were used very frequently.

Incidence of febrile episodes and hyperpyrexia were equal in both groups in initial period, but with the use of honey, it was observed that there was reduced incidence of febrile episodes and hyperpyrexia in group – I (20%) as compared to group - II (70%).

This was mainly because of deep invasive wound infection that solely occurred in group II, as hot, humid, hypoxic atmosphere favoured rapid bacterial proliferation. Although surface bacterial contamination was observed on culture in all patients of group-I, but deep invasive infections was remarkably absent.

Swab culture in would infection exhibited pseudomonas, proteus and staphylococcus as commonest offending organism. Group I exhibited staphylococcus as commonest pathogen while in group II, it was pseudomonas that was predominant. There was equal incidence of anaemia in both groups.
    
As depicted in table-4, leucocytosis in group II was mild in 60%, whereas incidence of significant leucocytosis in 65% of patients. Leucocytosis after second week was significantly more in group II (65%) as compared to group I. Liver and renal profile for biochemical parameters exhibited insignificant difference in both the groups. One remarkable observation was that most of the patients were ambulatory from 4th to 6th post burn day in group I, whereas in group II most of the patients were bed-ridden for a significantly prolonged period.

Table-1: Baseline characteristics of Honey and silver sulfadiazine dressing group

Variables

Honey application n = 95

Silver sulfadiazine group n = 93

Age in Years

Mean - 19.72, S.D. – 16.24

Mean - 23.95

S.D. – 13.5

Gender

Male – 12(12.63%)

Female – 83(87.36%)

Male – 9(9.67%)

Female – 84 (90.32%)

No. of febrile episode

20

70

Haemoglobin gm%

Mean 10.6 S.D. - 1.6

Mean 9.5

S.D. - 1.4

Serum Protein gm%

Mean 7.2 S.D. – 0.68

Mean 6.9

S.D. – 0.64


Table -2: Outcome honey dressing group

Variables

Median (Range)

Honey dressing Group (N=95)

P value

0 weeks

2nd week

4th week

6th week

Surface area of burn wound in percentage

28.05%

(15-49%)

20.08%

(10-40%)

13.75%

(8-30%)

2.91%

(0-15%)

0.000

Pain score during dressing Change

7 (0-10)

5 (0-10)

2.5(0-6)

1(0-4)

0.000

Overall comfort score of dressing

4 (3-7)

6(4-9)

8(4-10)

9(7-10)

0.000


Table- 3: Outcome Silver sulfadiazine dressing room

Variables

Median (Range)

Silver sulfadiazine (N=93)

P value

0 weeks

2nd week

4th week

6th week

Surface area of burn wound in percentage

27.67 %

(15-49%)

19.55%

(10-40%)

17.98%

(8-30%)

8.56%

(0-20%)

0.000

Pain score during dressing Change

7 (0-10)

5 (0-10)

5(0-9)

5(0-9)

0.000

Overall comfort score of dressing

4 (2-7)

5(3-8)

6(4-7)

6(4-8)

0.000


Table-4: Showing Leucocytosis Pattern in Group I and II

Leukocyte Count

Group I

Group II

Physiological range (4000 to 6000/cu.mm)

20%

10%

Mild leucocytosis (12000 to 18000/cu.mm)

50%

60%

Significant Leucocytosis (more than 18000/cu.mm)

30%

52%


Table-5: Showing Frequency of Isolates in Culture Positive Cases of Group I

Organism

Number of Culture positive

Samples (%)

(Total no. of samples n=95x3)

Staphylococcus Species

82 (28.7)

Proteus species

74 (25.9)

Enterobacter

48 (16.8)

Klebsiella

32 (11.2)

Pseudomonas Species

16 (5.6)

Enterococcus species

12 (4.2)

Others

8 (2.8)


Table-6: Showing Frequency of Isolates in Culture Positive Cases of Group II

Organism

Number of Culture positive

Samples (%)

(Total no. of samples n=95x3)

Pseudomonas Species

160 (56.1)

Proteus species

44 (15.4)

Staphylococcus Species

32 (11.2)

Enterobacter

18 (6.3)

E coli

11 (3.8)

Enterococcus species

08 (2.8)

Others

07 (2.4)


Discussion

Majority of the subjects – 75.10% in the honey dressing group and 61.5% in the silver sulfadiazine group were having flame/ flash burn aetiology [11, 12]. Several authors have reported that honey enhances wound healing rate, compared to other conventional or topical application in varieties of clinical condition including burn [12,13,14,15].
    
Our results with honey were similar to reports in literature showing rapid healing with the application of honey [15]. Hamdy et al (1988) reported that number of micro organisms and bacterial species decreased by 50-100% on application of honey on infected wounds [16]. Various authors reported mild or no pain at all during application of honey as compared to other treatments [17, 18, 19].

In our study, 54.7% of the subjects in the honey group achieved complete healing at 6th week. Medhi et al (2008) reported similar findings by conducting a meta-analysis to evaluate the efficacy of topical application of honey in studies as well as in clinical trials [20]. Barillo et al (2008) observed that honey topical application makes the wound dry [21] and creates a hard coagulum to minimise exudation and fluid loss (escharotics) [22,23].

Amongst the diverse variety of substances advocated for topical application in burn wound management, honey local application is non-irritant and cost effective [24,25]. In this study, most of the burn wounds healed in 6 weeks in absence of severe sepsis, even without skin grafting. In this trial, the reduced infection in burn wound might also be attributed to early weaning from intravenous fluids and early acceptance of oral feeding as compared to subjects in group II.

Conclusion

The present randomized trial is unique in the sense that burn patient often faces difficulty in dressing i.e. lack of meticulous technique in terms of infrastructure, manpower and material. The gauges and bandages are expensive items required in bulk and are usually out of stock in hospital. This trial also demonstrates that the rate of wound healing with silver sulfadiazine was much slower than that achieved in honey treated group. In search of cost effective burn wound management, use of honey proved to be a better alternative to early active management in well equipped burn units available at very high cost.
    
Education on first aid management on burn wound is the need of the hour in developing states like Chhattisgarh where most of the patients do not use running water as immediate remedial measures. It may be recommended that honey local application should be used as home treatment of less severe burn, even up to 20-25%.
    
Honey dressing is more effective as compared to silver sulfadiazine dressing in achieving complete healing, reducing burn surface area, pain and increasing comfort in subject with burn wounds.

Funding: Nil, Conflict of interest: None initiated
Permission from IRB: Yes

References


1. Zumla A, Lulat A. Honey--a remedy rediscovered. J R Soc Med. 1989 Jul;82(7):384-5. [PubMed]

2. Armon PJ. The use of honey in the treatment of infected wounds. Trop Doct. 1980 Apr;10(2):91.
[PubMed]

3. Molan PC The evidence supporting the use of honey as a wound dressing. Int J Low Extrem. 2006;5:40.


4. Efem SE. Clinical observations on the wound healing properties of honey. Br J Surg. 1988 Jul;75(7):679-81.
[PubMed]

5. Molan PC, Betts JA. Clinical usage of honey as a wound dressing: an update. J Wound Care. 2004 Oct;13(9):353-6.
[PubMed]

6. White JW Composition of honey. In: Crane E (ed) Honey: a comprehensive survey. Heinemann, London. 1975;pp157-206. 


7. Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005 Jun;44(6):449-56. [PubMed]

8. Yapucu Güneş U, Eşer I. Effectiveness of a honey dressing for healing pressure ulcers. J Wound Ostomy Continence Nurs. 2007 Mar-Apr;34(2):184-90.


9. Okeniyi JA, Olubanjo OO, Ogunlesi TA, Oyelami OA. Comparison of healing of incised abscess wounds with honey and EUSOL dressing. J Altern Complement Med. 2005 Jun;11(3):511-3.
[PubMed]

10. Subrahmanyam M A prospective randomized clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns. 1988;24(2):157-161.
[PubMed]

11. Borgstein ES – Standard guidelines for burn treatment. Burn Manual. 2008. www.ptolemy.ca/downloads (accessed on October 24, 2009).


12. Allorto NL, Oosthuizen GV, Clarke DL, Muckart DJ. The spectrum and outcome of burns at a regional hospital in South Africa. Burns. 2009 Nov;35(7):1004-8. doi: 10.1016/j.burns.2009.01.004. Epub 2009 May 17.
[PubMed]

13. Subrahmanyam M Honey-impregnated gauze versus amniotic membrane in the treatment of burns. Burns.1994;20(4):331-333.
[PubMed]

14. Ndayisaba G, Bazira L, Habonimana E, Muteganya D Clinical and bacteriological results in wounds treated with honey. J Orthop Surg.1993;7(2):202-204.


15. Weheida SM, Nagubi HH, El-Banna HM, Marzouk S Comparing the effects of two dressing techniques on healing of low grade pressure ulcers. J Med Res Inst.1991;12(2):259-278. 


16. Hamdy MH, El Banby MA, Khakifa KI, GadEm The antimicrobial effect of honey in the management of septic wounds. Proceedings of the Fourth International Conference on Apiculture in Tropical Climates, Cairo, Egypt 6-10 November London, UK; International Bee Research Association. 1988.


17. Mphande AN, Killowe C, Phalira S, Jones HW, Harrison WJ. Effects of honey and sugar dressings on wound healing. J Wound Care. 2007 Jul;16(7):317-9.
[PubMed]

18. Subrahmanyam M. Topical application of honey in treatment of burns. Br J Surg. 1991 Apr;78(4):497-8.
[PubMed]

19. Medhi B, Puri A, Upadhyay S, Kaman L Topical application of honey in the treatment of wound healing: a meta analysis. Alternative Med. 2008;10(4):166-169.


20. Atiyeh BS, Al-Amm CA, El-Musa KA, Sawwaf A, Dham R The effect of moist and moist exposed dressings on healing and barrier function restoration of partial thickness wounds. Eur J Plast Surg. 2003;26:5-11.


21. Barillo DJ – Topical antimicrobials in burn wound care. WOUND 2008. www.woundresearch.com (accessed October 24, 2009). 


22. Aldrich RH – The role of infection in burns; the theory and treatment with special reference to gentian violet. N Engl J Med 1933;208:299-309.


23. Ross JA, Hulbert KF. Treatment of Burns by Silver Nitrate, Tannic Acid, and Gentian Violet. Br Med J. 1940 Nov 23;2(4168):702-3.
[PubMed]

24. State Health Resource Centre, Chhattisgarh – Standard Treatment Guidelines for Medical Officers, 2003. www.shsrc.org (accessed October 12, 2009).


25. Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J. 2009 May 22;122(1295):47-60.
[PubMed]



How to cite this article?

K. N. Choudhary, S. K. Mohanty, P. Soni. A prospective randomized trial to compare the effectiveness of honey vs. silver sulfadiazine dressing in burn wound management. Int J Med Res Rev 2016;4(1): 67-74. doi:10.17511/ijmrr.2016.i01.011.